Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure
Top Cited Papers
- 3 April 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 115 (13) , 1754-1761
- https://doi.org/10.1161/circulationaha.106.653964
Abstract
Background— In patients with systolic heart failure, high levels of circulating aldosterone are associated with an adverse prognosis, and mineralocorticoid receptor blockade improves survival. The prognostic significance of cortisol that may also bind and activate the mineralocorticoid receptor in chronic heart failure is unknown. Methods and Results— Serum levels of cortisol and aldosterone were quantified in a prospective cohort study of 294 consecutive patients with chronic heart failure [48% were in New York Heart Association functional class III or IV; 58% had systolic heart failure]. During a median follow-up of 803 days (interquartile range, 314 to 1098), 79 patients died (27.3% mortality rate). Cortisol and aldosterone were independent predictors of increased mortality risk in Cox regression analyses adjusted for age, sex, New York Heart Association functional class, C-reactive protein, N-terminal pro-brain natriuretic peptide, sodium, and hypercholesterolemia. The hazard ratio for highest versus ...Keywords
This publication has 36 references indexed in Scilit:
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failurePublished by Elsevier ,2010
- High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial InfarctionCirculation, 2006
- Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive RatsHypertension, 2006
- Suppression of the Renin–Angiotensin–Aldosterone System in Chronic Heart FailureCardiology in Review, 2006
- Aldosterone antagonism in heart failure: improvement of cardiac remodelling, endothelial dysfunction and platelet activationEuropean Journal of Clinical Investigation, 2004
- Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular diseaseJournal of the Renin-Angiotensin-Aldosterone System, 2003
- Angiotensin II Receptor Antagonists in Chronic Heart FailureDrugs, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effectiveness of Spironolactone Added to an Angiotensin-Converting Enzyme Inhibitor and a Loop Diuretic for Severe Chronic Congestive Heart Failure (The Randomized Aldactone Evaluation Study [RALES])**See Appendix for full list of RALES investigators.The American Journal of Cardiology, 1996
- Predictors of total mortality and sudden death in mild to moderate heart failureJournal of the American College of Cardiology, 1989